Creating Value through Personalized Medicine

Contributed by:

Denise Myshko

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

BY DENISE MYSHKO

The use of pharmacogenomics to develop personalized medicine will lead to a culture change for the pharmaceutical industry. While initially disruptive, personalized medicine will lead to longer-term success for pharmaceutical companies. Dr. Gary Kurtzman Safeguard Scientifics There will be a greater impetus on pharmaceutical companies to demonstrate that their products are an improvement over the existing standard of care and to identify which patients will have unwanted side effects.

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK